Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT02775786What this trial is testingProspective Evaluation of MRI Biomarkers in Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma Columbia University 47
Testing effectiveness (Phase 2)Temporarily pausedNCT00536770What this trial is testingGemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Novacea 132
Testing effectiveness (Phase 2)UnknownNCT02455596What this trial is testingRecombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 20
Very early researchLooking for participantsNCT06122896What this trial is testingProspective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk IndividualsWho this might be right forPancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+2 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04753879What this trial is testingMulti-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Who this might be right forMetastatic Pancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableLooking for participantsNCT06666803What this trial is testingFunctional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)Who this might be right forPDAC - Pancreatic Ductal Adenocarcinoma IHU Strasbourg 60
Early research (Phase 1)Study completedNCT05440942What this trial is testingCombined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Peter Hosein, MD 28
Testing effectiveness (Phase 2)Looking for participantsNCT07096362What this trial is testingUtility of ctDNA in Early Switch of First-line Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forMetastatic Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma University of Miami 50
Testing effectiveness (Phase 2)Study completedNCT00967603What this trial is testingMaintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer IRCCS San Raffaele 56
Testing effectiveness (Phase 2)Study completedNCT02074046What this trial is testingSafety Study of Cancer Stem Cell Vaccine to Treat Pancreatic CancerWho this might be right forNeoplasms, Pancreas Fuda Cancer Hospital, Guangzhou 40
Not applicableStudy completedNCT04348084What this trial is testingOncologic Impact of Pancreatic FistulaWho this might be right forPDAC of the Body and the Tail of the PancreasCR- POPF University Hospital, Montpellier 382
Early research (Phase 1)Study completedNCT01188785What this trial is testingPhase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the PancreasWho this might be right forPancreatic Ductal AdenocarcinomaPancreatic Cancer Silenseed Ltd 15
Large-scale testing (Phase 3)Study completedNCT00003049What this trial is testingSurgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the PancreasWho this might be right forPancreatic Cancer Mayo Clinic 100
Not applicableLooking for participantsNCT06698458What this trial is testingAlpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerWho this might be right forPancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer Alpha Tau Medical LTD. 50
Early research (Phase 1)Study completedNCT01478685What this trial is testingCC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsWho this might be right forUrinary Bladder NeoplasmsCarcinoma, Transitional CellOvarian Neoplasms+5 more Celgene 169
Early research (Phase 1)WithdrawnNCT02048943What this trial is testingDovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWho this might be right forDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more Roswell Park Cancer Institute
Early research (Phase 1)Looking for participantsNCT06596915What this trial is testingSafety and Efficacy of BA1302 in Patients With Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more Shandong Boan Biotechnology Co., Ltd 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT03483038What this trial is testingThe Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma University of Florida 45
Testing effectiveness (Phase 2)Ended earlyNCT01392352What this trial is testingHYPAZ: Hypertension Induced by PazopanibWho this might be right forRenal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more Cambridge University Hospitals NHS Foundation Trust 31